News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Infectious Diseases. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Northwestern Medicine investigators have continued to examine COVID-19, from the impact of prone positioning during treatment to vaccine protection against the Omicron variant in children.
Feinberg’s Medical Faculty Council recently honored the recipients of the 2022 Mentor of the Year award at a virtual mentoring workshop.
In this feature story, Northwestern scientists share their work at the forefront of HIV research, pioneering new strategies to investigate, treat, and work towards a cure for the disease.
New advances in CRISPR gene-editing technology may lead to longer-lasting treatments and new therapeutic strategies for HIV/AIDS.
Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
Frank Palella, MD, is working towards increasing the lifespan and “healthspan” of people living with HIV through research, education and patient care as director of the new Potocsnak Center for Aging and HIV.
Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.
A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
Medical students performed comedy skits and musical numbers that satirized the medical school experience at In Vivo, Feinberg’s annual sketch comedy and variety show.
Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.
A recent Northwestern Medicine study found global efforts to track variants grossly underreported a probable variant of concern, Eta, circulating in Nigeria in early 2021.
A new study has identified naturally occurring nano-sized particles that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.
Feinberg experienced a year of exceptional growth, perseverance, and collaboration in 2021, from honors and awards to unprecedented research discoveries.
Feinberg’s Robert J. Havey, MD Institute for Global Health hosted the 10th annual Global Health Day symposium on December 3, featuring keynote speakers, online poster presentations, and question and answers sessions.
Northwestern Medicine scientists continue to tackle every facet of the COVID-19 pandemic, from investigating coronavirus vaccines’ potential for providing immunity against similar coronaviruses to developing novel rapid antigen-based tests and examining disparities in COVID-19 case and mortality rates in Chicago.
Through the Robert J. Havey, MD Institute for Global Health, Feinberg faculty across disciplines are training investigators from Africa, many of whom are enrolled in Feinberg graduate programs, on how to effectively conduct research about diseases currently impacting their home countries.
Human cells use a protein named TBC1D5 to “trap and kill” influenza A viruses inside host cells, but the virus encodes its own protein to disable this defense.
Northwestern University Trustees and alumni Patrick G. Ryan and Shirley W. Ryan have made a historic gift to name and endow the Robert J. Havey, MD Institute for Global Health.
Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.
The Northwestern Medicine Comprehensive COVID-19 Center is committed to caring for and conducting research on behalf of patients who experience long-term complications from COVID-19.
Northwestern Medicine investigators continue to assess COVID-19 treatments for mild to severe cases, the widespread adoption of telemedicine, and why a “return to normal” will be a missed opportunity to improve healthcare.
The Institute for Global Health (IGH) has established the Center for Pathogen Genomics and Microbial Evolution which will apply lessons learned during the COVID-19 pandemic to the tracking and prevention of future threats.
It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.
Since March 2020, a team of Northwestern Medicine scientists have been tracking the evolution of SARS- CoV-2, specifically in the city of Chicago. Their work has been pivotal in understanding how the virus spread to Chicago and what new variants have emerged in the city.
Three Feinberg students have received Harvard-BU-Northwestern-University of New Mexico Fogarty Global Health Fellowships, supporting work in Botswana, South Africa and Tanzania.
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
Listen to the year’s most popular episodes of the Breakthroughs podcast, featuring Northwestern Medicine experts discussing COVID-19 research.
Northwestern Medicine physicians have begun receiving their vaccines, an experience that for many was inspiring, sobering and hopeful. Read the reactions of a few Northwestern Medicine physicians upon receiving their COVID-19 vaccines.
In late March, the world came to a virtual standstill. The COVID-19 pandemic forced leaders around the world to limit large gatherings and shutter schools and businesses. For Feinberg’s research enterprise, this was a serious disruption — but science kept moving forward.